41 records matched your query
03512nam a22004454a 4500 001 E3B557902B0511DE80C1F007A8D7520A 005 200904162311.0 008 010806s2001 paua b 001 0 eng 010 $a 2001038689 020 $a 9780781722698 020 $a 0781722691 035 $a (OCoLC)47756557 040 $a DNLM $c NLM $d SILO $d VAM $d MUQ $d EYE $d IWA $d SILO 050 00 $a RC271.C5 $b C32219 2001 060 10 $a QZ 267 $b C21515 2001 082 00 $a 616.99/4061 $2 21 245 0 $a Cancer chemotherapy and biotherapy : $b principles and practice / $c edited by Bruce A. Chabner, Dan L. Longo. 250 $a 3rd ed. 260 $a Philadelphia : $b Lippincott Williams & Wilkins, $c c2001. 300 $a xii, 1140 p. : $b ill. ; $c 29 cm. 504 $a Includes bibliographical references and index. 505 0 $a Ch. 1. Clinical strategies for cancer treatment: the role of drugs -- Ch. 2. Preclinical aspects of cancer drug discovery and development -- Ch. 3. Pharmacokinetics and clinical monitoring -- Ch. 4. Infertility after cancer chemotherapy -- Ch. 5. Carcinogenesis: a late complication of cancer chemotherapy -- Ch. 6. Steroid hormone therapies for cancer -- Ch. 7. Antifolates -- Ch. 8. 5-fluoropyrimidines -- Ch. 9. Cytidine analogs -- Ch. 10. Purine antimetabolites -- Ch. 11. Hydroxyurea -- Ch. 12. Antimicrotubule agents -- Ch. 13. Alkylating agents -- Ch. 14. Nonclassic alkylating agents -- Ch. 15. Cisplatin and analogs -- Ch. 16. Bleomycin -- Ch. 17. Antitumor antibiotics -- Ch. 18. Anthracyclines and anthracenediones -- Ch. 19. Topoisomerase II inhibitors: epipodophyllotoxins, acridines, ellipticines, and bisdioxopiperazines -- Ch. 20. Topoisomerase I targeting agents: the camptothecins -- Ch. 21. Enzyme therapy: L-asparaginase -- Ch. 22. Pharmacologic considerations in chemotherapy for brain tumors -- Ch. 23. Retinoids and other differentiating agents -- Ch. 24. Bisphosphonates -- Ch. 25. Radiation modifiers -- Ch. 26. Pharmacology of interferons: induced proteins, cell activation, and 505 0 $a antitumor activity -- Ch. 27. Clinical pharmacokinetics of interleukin 1, interleukin 2, interleukin 4, tumor necrosis factor, interleukin 12, and macrophage colony-stimulating factor -- Ch. 28. Colony-stimulating factors -- Ch. 29. Antibody-based immunotherapies for cancer -- Ch. 30. Targeted therapy -- Ch. 31. Physical barriers to drug delivery -- Ch. 32. Adoptive cellular therapy -- Ch. 33. Cancer vaccines 2001 -- Ch. 34. Cytokine and growth factor and receptor database: biologic, molecular, and pathophysiologic properties of ligand-receptor interactions -- Ch. 35. Inhibitors of tumor angiogenesis -- Ch. 36. Pharmacogenetics -- Ch. 37. Chemokine-chemokine receptor database 2001: biologic, molecular, and pathophysiologic properties of chemokine-receptor interactions. 650 0 $a Cancer $x Chemotherapy. 650 0 $a Cancer $x Immunotherapy. 650 0 $a Antineoplastic agents. 650 0 $a Biological response modifiers. 650 2 $a Neoplasms $x Drug therapy. 650 2 $a Antineoplastic Agents $x therapeutic use 650 2 $a Biological Products $x therapeutic use. 650 6 $a Cancer $x ChimiotheÌrapie 650 6 $a Cancer $x ImmunotheÌrapie 700 1 $a Chabner, Bruce. 700 1 $a Longo, Dan L. $q (Dan Louis), $d 1949- 939 $a 5048979 941 $a 2 952 $l USUX851 $d 20240305042856.0 952 $l OVUX522 $d 20171227035837.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=E3B557902B0511DE80C1F007A8D7520A 994 $a 02 $b IWAInitiate Another SILO Locator Search